Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 12, 2020

SELL
$119.05 - $147.35 $354,769 - $439,103
-2,980 Closed
0 $0
Q4 2019

Feb 13, 2020

BUY
$106.92 - $132.43 $318,621 - $394,641
2,980 New
2,980 $392,000
Q3 2019

Nov 13, 2019

SELL
$106.79 - $116.16 $2.4 Million - $2.61 Million
-22,454 Closed
0 $0
Q2 2019

Aug 13, 2019

SELL
$110.79 - $129.32 $2.82 Million - $3.29 Million
-25,454 Reduced 53.13%
22,454 $2.49 Million
Q1 2019

May 13, 2019

BUY
$111.31 - $131.02 $5.33 Million - $6.28 Million
47,908 New
47,908 $6.22 Million
Q3 2018

Nov 13, 2018

SELL
$85.86 - $107.31 $6.59 Million - $8.24 Million
-76,768 Closed
0 $0
Q2 2018

Aug 13, 2018

BUY
$75.7 - $86.88 $5.81 Million - $6.67 Million
76,768 New
76,768 $6.55 Million
Q4 2017

Feb 12, 2018

SELL
$81.94 - $87.89 $930,510 - $998,078
-11,356 Closed
0 $0
Q3 2017

Nov 13, 2017

BUY
$77.07 - $85.54 $875,206 - $971,392
11,356
11,356 $971,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Kepos Capital LP Portfolio

Follow Kepos Capital LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kepos Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Kepos Capital LP with notifications on news.